Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial (Q90988232)
Jump to navigation
Jump to search
scientific article published on 07 January 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial |
scientific article published on 07 January 2019 |
Statements
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial (English)
Florian von Groote-Bidlingmaier
Ramonde Patientia
Epifanio Sanchez
Vincent Balanag
Eduardo Ticona
Patricia Segura
Elizabeth Cadena
Charles Yu
Andra Cirule
Victor Lizarbe
Edita Davidaviciene
Liliana Domente
Ebrahim Variava
Janice Caoili
Manfrid Danilovits
Virgaine Bielskiene
Suzanne Staples
Norbert Hittel
Carolyn Petersen
Charles Wells
Jeffrey Hafkin
Lawrence J Geiter